Site icon Trade Solutions Pro

Insiders Favor These 3 Leading Growth Companies

Insiders Favor These 3 Leading Growth Companies

As February begins, U.S. stock markets are showing strong momentum, with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this environment of market optimism, investors often look for growth companies with high insider ownership as an indicator of confidence and potential resilience amidst economic shifts.

Top 10 Growth Companies With High Insider Ownership In The United States

Name Insider Ownership Earnings Growth Upstart Holdings (UPST) 12.5% 51.5% StubHub Holdings (STUB) 22.9% 59.8% SES AI (SES) 12.2% 68.9% Ryan Specialty Holdings (RYAN) 15.3% 50.3% QT Imaging Holdings (QTI) 22.8% 76% Karman Holdings (KRMN) 17.3% 62% Duos Technologies Group (DUOT) 17.4% 155.1% Atour Lifestyle Holdings (ATAT) 17.3% 24.3% Astera Labs (ALAB) 10.4% 29.0% AppLovin (APP) 27.4% 21%

Click here to see the full list of 200 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let’s explore several standout options from the results in the screener.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: CarGurus, Inc. operates an online automotive platform for buying and selling vehicles both in the United States and internationally, with a market cap of approximately $2.65 billion.

Operations: CarGurus generates revenue primarily from its U.S. Marketplace segment, which accounts for $801.72 million, and its Digital Wholesale segment, contributing $50.35 million.

Insider Ownership: 14.7%

Earnings Growth Forecast: 21.3% p.a.

CarGurus is poised for significant earnings growth, with forecasts suggesting a 21.3% annual increase, surpassing the US market average. Despite trading at 75.7% below its estimated fair value, revenue growth is expected to lag behind the broader market at 6.1% annually. The recent launch of PriceVantage aims to enhance dealer profitability through advanced pricing insights, potentially bolstering CarGurus’ competitive edge and supporting its high forecasted return on equity of 49.4%.

CARG Ownership Breakdown as at Feb 2026
CARG Ownership Breakdown as at Feb 2026

Simply Wall St Growth Rating: ★★★★★☆

Overview: Figure Technology Solutions, Inc. is a financial technology company offering blockchain-based products and solutions in the United States, with a market cap of $7.97 billion.

Operations: Figure Technology Solutions, Inc. does not have specified revenue segments available in the provided text.

Insider Ownership: 27.1%

Earnings Growth Forecast: 52.3% p.a.

Figure Technology Solutions anticipates robust growth, with revenue and earnings projected to outpace the US market significantly. Despite recent executive changes, including a new CEO, insider buying has exceeded selling over the last three months. The company completed a US$150 million equity offering and expects substantial revenue and profit growth for 2025. Figure’s expansion into blockchain-based lending through its RWA consortium underscores its innovative approach in bridging traditional finance with decentralized finance opportunities.

FIGR Ownership Breakdown as at Feb 2026

Simply Wall St Growth Rating: ★★★★★☆

Overview: ImmunityBio, Inc. is a commercial stage biotechnology company focused on developing next-generation therapies to enhance natural immune systems against cancers and infectious diseases, with a market cap of $8.41 billion.

Operations: The company generates revenue of $82.56 million from its efforts in advancing innovative therapies designed to strengthen the body’s immune response against cancers and infectious diseases.

Insider Ownership: 30%

Earnings Growth Forecast: 62.7% p.a.

ImmunityBio’s growth potential is underscored by its high insider ownership and recent regulatory approvals, including conditional marketing authorization in Europe for ANKTIVA® in bladder cancer treatment. Despite a volatile share price and past shareholder dilution, the company forecasts robust revenue growth of 51.9% annually, outpacing the US market. ImmunityBio’s strategic expansions into new markets like Saudi Arabia and advancements in immunotherapy platforms further bolster its position as a promising player in oncology therapeutics.

IBRX Ownership Breakdown as at Feb 2026

Key Takeaways

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.
It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.
All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

link

Exit mobile version